Business Wire

Prof. Stephen Wilhite Named AURAK Provost

Jaa

The American University of Ras Al Khaimah (AURAK) has this week announced Prof. Steven C. Wilhite as the university’s new provost and vice president for academic affairs and student success.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170716005019/en/

New AURAK Provost, Prof. Stephen Wilhite (Photo: ME NewsWire).

New AURAK Provost, Prof. Stephen Wilhite (Photo: ME NewsWire).

Prof. Wilhite, who joins the university in time for the 2017/18 academic year, brings a wealth of experience to the role. He served as provost at Widener University, Philadelphia, since 2011, as well as a period as interim president from 2015 to 2016. He also served a number of other leadership positions at Widener, such as associate provost for graduate studies, and dean of the School of Human Service Professions.

Commenting on the new appointment, AURAK president, Prof. Hassan Hamdan Al Alkim stated, “We have made significant progress over the last year, culminating in the university being granted candidacy by the Southern Association of Colleges and Schools Commission on Colleges (SACSCOC). In Prof. Wilhite, we have another outstanding administrator joining our team, who will no doubt significantly contribute to the advancement of AURAK and the attainment of our goals.”

Originally from Tennessee, Prof. Wilhite earned his bachelor’s degree in psychology from Emory University, Atlanta, U.S., where he graduated with highest honors. Upon completion of his undergraduate studies, he was awarded a Marshall Scholarship to attend the University of Oxford, England, earning a Ph.D. in Human Experimental Psychology.

Prof. Wilhite was a participant in a year-long institute for New Chief Academic Officers with the American Council on Education, attended the Management and Leadership in Education Institute at Harvard University, and had a two-year post-doctoral fellowship at the University of Illinois.

With AURAK striving for SACSCOC institutional accreditation, Prof. Wilhite also has invaluable experience. He has been a member of accreditation site visit teams for the Middle States Commission on Higher Education.

Prof. Wilhite authored the book, Learning and Memory: The Basis of Behavior (1992) and edited the book, Civic Engagement and Service Learning in a Metropolitan University: Multiple Approaches and Perspectives (2011). In total, he has more than thirty publications and has presented more than fifty scholarly papers.

Prof. Wilhite’s current research interests include applied cognitive psychology and educational psychology, especially in relation to civic and community engagement, emotional competence, higher education leadership, and faculty development.

*Source: ME NewsWire

Contact information

AURAK
Eoin Brown, +97172210900 Ext: 1325
Communications and Public Relations Department
eoin.brown@aurak.ac.ae

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Ipsen Receives Approval from European Commission for Xermelo® (Telotristat Ethyl) for the Treatment of Carcinoid Syndrome Diarrhea in Patients Inadequately Controlled by Somatostatin Analogue Therapy19.9.2017 19:00Tiedote

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced that the European Commission has approved Xermelo® (telotristat ethyl) 250 mg three times a day (tid) for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analogue (SSA) therapy in adults inadequately controlled by SSA therapy. This approval allows for the marketing of Xermelo® (telotristat ethyl) in the above indication in all 28 member states of the European Union, Norway and Iceland. David Meek, Chief Executive Officer, Ipsen stated: “We are delighted to provide patients suffering from inadequately controlled carcinoid syndrome with a new treatment option in combination with a somatostatin analogue that demonstrates both efficacy and safety in particularly improving diarrhea, a most debilitating symptom. Xe

6th Annual World Patient Safety, Science & Technology Summit to Be Held in London, England19.9.2017 18:00Tiedote

The Patient Safety Movement Foundation (PSMF) announces that the 6th Annual World Patient Safety, Science & Technology Summit will take place in London on February 23-25, 2018. Rt. Hon. Jeremy Hunt MP, the Secretary of State for Health from England’s Department of Health, invited PSMF to hold its 6th annual Summit in London during his speech at the Summit in February of this year. This is the first time the Summit will be held outside of the United States. Over the years, the PSMF has taken an increasingly international scope to reach zero preventable patient deaths by 2020. They currently have over 30 Regional Chapters around the world and partnerships with global organizations such as the World Federation of Societies of Anaesthesiologists (WFSA), European Society of Anaesthesiology (ESA), Global Sepsis Alliance (GSA), the Taiwan Patient Safety Culture Club, Sistema Españo

Vertex Announces Upcoming Presentations of Data at 2017 North American Cystic Fibrosis Conference19.9.2017 17:50Tiedote

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that 11 abstracts from its cystic fibrosis (CF) research and development program will be presented at the annual North American Cystic Fibrosis Conference (NACFC) in Indianapolis, November 2 to 4, 2017. Previously announced data from the Phase 3 EVOLVE and EXPAND studies of the investigational tezacaftor/ivacaftor combination in people with CF ages 12 and older who have certain mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene will be presented for the first time. Additionally, data from the Phase 3 extension study of ORKAMBI® (lumacaftor/ivacaftor) in children with CF ages 6 to 11 who have two copies of the F508del mutation and real-world KALYDECO® (ivacaftor) data will be presented. The company also submitted an abstract for the late-breaking poster session with previously announced Phase 1

Biker Summer 2017 campaign: Last Chance to Win Great Prizes from Moto-tyres.co.uk19.9.2017 16:57Tiedote

Moto-tyres.co.uk wants to know: For the fifth year in a row, the online motorbike shop is asking bikers from ten European countries about their Biker Summer 2017 travel plans, favourite destinations and longest tours. For survey participants, Moto-tyres.co.uk and its sister shops in other European countries are raffling prizes to get every biker’s heart beating faster, including vouchers for new motorbike tyres, a GARMIN motorbike GPS navigation system, and a GoPro camera with helmet attachment. For more information and a link to the survey, go to: www.moto-tyres.co.uk/promotion-biker-summer-2017.html. The Biker Summer 2017 campaign is running until 30th September 2017 – so you still have time to join in and win top-quality equipment for your next bike tour. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170919006105/en/

Andersen Global Expands into Uruguay19.9.2017 16:30Tiedote

Andersen Global announces its expansion into Uruguay through a Collaboration Agreement with Fischer & Schickendantz, one of the country’s leading law firms. The addition of Fischer & Schickendantz continues Andersen Global’s expansion and robust presence within the Latin American region. The team is led by Managing Partner, Juan Federico Fischer. “The addition of Juan Federico and the individuals at Fischer & Schickendantz bring a new depth to our team and our business development efforts in South America, while allowing us to deliver additional services in the region,” said Andersen Tax CEO, Mark Vorsatz. “Uruguay is the next major step in our firm’s growth and is an excellent complement for Andersen Global. The ability to provide a full scope of services in Uruguay offers significant advantages, especially given their large cross border client base and Uruguay’s increase

Horizon Petroleum Enters into Definitive Agreements to Acquire Concessions in Poland19.9.2017 16:05Tiedote

Horizon Petroleum Ltd. (the “Company” or “Horizon”) (TSXV:HPL) is pleased to report that further to its press releases dated June 23, 2017, and July 26, 2017, it has entered into a series of definitive agreements (the “Agreements”) with Dublin-based San Leon Energy plc (“SLE”) regarding the purchase from wholly-owned subsidiaries of SLE and other SLE-controlled entities, of 100% interests in 2 oil & gas concessions in the Republic of Poland known as Cieszyn and Bielsko-Biala (the “Primary Concessions”), plus 100% working interests in 2 additional oil & gas concessions in Poland known as Prusice and Kotlarka, and another concession which is under application (together the “Secondary Concessions”). These concessions cover 3,030km2 and lie within the prolific Rotliegendes Basin and Carpathian Foldbelt, where Horizon intends to target undeveloped conventional natural gas discoveries. Gas infr

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme